BCYC
Bicycle Therapeutics Plc - ADR

874
Mkt Cap
$281.11M
Volume
203,555.00
52W High
$13.11
52W Low
$5.27
PE Ratio
-1.55
BCYC Fundamentals
Price
$5.54
Prev Close
$5.63
Open
$5.60
50D MA
$6.76
Beta
1.09
Avg. Volume
252,815.75
EPS (Annual)
-$2.91
P/B
0.63
Rev/Employee
$115,704.40
$55.12
Loading...
Loading...
News
all
press releases
Bicycle Therapeutics (NASDAQ:BCYC) Trading Down 2.6% - Time to Sell?
Bicycle Therapeutics (NASDAQ:BCYC) Stock Price Down 2.6% - Time to Sell...
MarketBeat·14h ago
News Placeholder
More News
News Placeholder
Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline
Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today...
Business Wire·8d ago
News Placeholder
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives Consensus Recommendation of "Hold" from Brokerages
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) has been given a consensus rating of "Hold" by the thirteen research firms that are presently covering the stock, MarketBeat...
MarketBeat·22d ago
News Placeholder
Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026
Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today...
Business Wire·1mo ago
News Placeholder
Bicycle Therapeutics (NASDAQ:BCYC) CEO Sells $70,210.00 in Stock
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) CEO Kevin Lee sold 10,325 shares of the company's stock in a transaction dated Friday, January 2nd. The shares were sold at an...
MarketBeat·1mo ago
News Placeholder
Bicycle Therapeutics (NASDAQ:BCYC) CEO Kevin Lee Sells 10,989 Shares
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) CEO Kevin Lee sold 10,989 shares of the business's stock in a transaction dated Monday, January 5th. The stock was sold at an...
MarketBeat·1mo ago
News Placeholder
Bicycle Therapeutics (NASDAQ:BCYC) COO Alistair Milnes Sells 3,244 Shares
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) COO Alistair Milnes sold 3,244 shares of the company's stock in a transaction on Friday, January 2nd. The stock was sold at an...
MarketBeat·1mo ago
News Placeholder
Insider Selling: Bicycle Therapeutics (NASDAQ:BCYC) COO Sells 3,416 Shares of Stock
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) COO Alistair Milnes sold 3,416 shares of the company's stock in a transaction dated Monday, January 5th. The shares were sold at...
MarketBeat·1mo ago
News Placeholder
Alethia Young Sells 3,289 Shares of Bicycle Therapeutics (NASDAQ:BCYC) Stock
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) CFO Alethia Young sold 3,289 shares of the stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an...
MarketBeat·1mo ago
News Placeholder
Insider Selling: Bicycle Therapeutics (NASDAQ:BCYC) CFO Sells 4,334 Shares of Stock
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) CFO Alethia Young sold 4,334 shares of the firm's stock in a transaction dated Monday, January 5th. The shares were sold at an...
MarketBeat·1mo ago
<
1
2
...
>

Latest BCYC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.